Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)

PHASE4CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

May 1, 2007

Primary Completion Date

August 17, 2009

Study Completion Date

August 17, 2009

Conditions
Ulcerative Colitis
Interventions
DRUG

MMX Mesalamine

MMX™ mesalamine 2.4g/day to 4.8g/day once-daily (QD) (two to four 1.2g tablets MMX™ mesalamine, dosed QD,respectively).

Trial Locations (62)

10128

Mount Sinai and Metropolitan Hospital, New York

11021

Long Island Clinical Research Associates, LLP, Long Island City

11030

North Shore University Hospital, Manhasset

11042

Digestive Medicine of Long Island, New Hyde Park

11501

Winthrop University Hospital, Mineola

11706

Western Suffolk Gastroenterology Associates, LLP, Bay Shore

12180

Upstate Gastroentrology Associates, Troy

18840

Guthrie Clinic, Sayre

20307

Walter Reed Army Medical Center, Washington D.C.

20707

Maryland Digestive Disease Research, LLC, Laurel

21401

Digestive Disorders Associates Research Division, Annapolis

Maryland Clinical Trials, Annapolis

23320

Gastroenterology Associates of Tidewater, Chesapeake

24073

New River Valley Research, Christiansburg

27262

Peters Medical Research, High Point

28546

East Carolina Gastroenterology, Jacksonville

30034

Soapstone Ctr. for Clin. Rsrch, Decatur

30060

NW GA Gastroenterology, Marietta

31201

Gastroenterology Assoc./Cen.GA, Macon

32168

United Medical Research, New Smyrna Beach

32256

Borland-Groover Clinic, Jacksonville

33021

Southern Clinical Research Consultants, Hollywood

33756

Advanced Digestive Care, PA, Clearwater

34684

Advanced Gastroenterology Associates, Palm Harbor

35209

Birmingham Gastroenterology Assoc., Birmingham

37404

ClinSearch, Chattanooga

37660

Holston Medical Group, Kingsport

38138

Gastroenterology of Midsouth, Germantown

44122

Gastroenterology Associates, Beachwood

45219

Consultants for Clinical Research, Inc., Cincinnati

45220

Digestive Health Network, Cincinnati

45242

Gastro Consultants of Greater Cincinnati, Cincinnati

45415

Gild Consultants, P.C., Dayton

46202

Indiana University Hospital, Indianapolis

48098

Center for Digestive Health, Troy

52242

University of Iowa Hospital and Clinics, Iowa City

52807

Gastrointestinal Clinic of Quad Cities, Davenport

53186

Aurora Health Center- Waukesha, Waukesha

53215

Wisconsin Center for Advanced Research, Milwaukee

53233

Aurora Sinai Medical Center, Milwaukee

55905

Mayo Clinic Rochester, Rochester

59718

Clinical Research Group of Montana, PLLC, Bozeman

61107

Rockford Gastroenterology Associates, Rockford

61265

Midwest Clinical Research Associates, Moline

61602

Accelovance, Peoria

65265

Center for Digestive and Liver Diseases, Mexico

66212

GI Associates, Overland Park

71103

Louisiana Research Center, LLC, Shreveport

72401

Clopton Clinic, Jonesboro

73069

Central Sooner Research, Norman

77024

Houston Endoscopy & Research Center, Houston

78229

Gastroenterology Clinic of San Antonio, San Antonio

80113

South Denver Gastroenterology, P.C., Englewood

90822

VA Medical Center - Long Beach, Long Beach

92101

Sharp Rees-Stealy Medical Group, San Diego

92103

Clinical Applications Laboratories, Inc., San Diego

99204

Inland Empire Gastroenterology, P.S., Spokane

Spokane Digestive Disease Center, P.S., Spokane

06830

The Center for GI Medicine of Fairfield & Westchester, P.C., Greenwich

06518

Medical Research Center of Connecticut, LLC, Hamden

06510

Connecticut Gastroenterology Associates, New Haven

07726

Marlboro Gastroenterology, Manalapan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT00446849 - Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) | Biotech Hunter | Biotech Hunter